Vimarsana
Biggest News Aggregation in the World

Small Molecule News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Molecule. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Molecule Today - Breaking & Trending Today

Global Super Generics Market Report 2024: A $200 Billion - Vimarsana News

Global Super Generics Market Report 2024: A $200 Billion

Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The

Agilent Technologies : Second Quarter 2024 Prepared Remarks - Vimarsana News

Agilent Technologies : Second Quarter 2024 Prepared Remarks

Agilent Technologies Second Quarter Fiscal 2024 Conference Call Prepared Remarks Parmeet Ahuja, Vice President, Investor Relations ...

Glycomimetics wilts on missed acute myeloid leukemia phase III - Vimarsana News

Glycomimetics wilts on missed acute myeloid leukemia phase III

Top-line data from Glycomimetics Inc.’s pivotal phase III study of uproleselan in 388 patients with relapsed/refractory acute myeloid leukemia missed its primary endpoint. The data crippled the stock, which closed at the low point of its 10-year existence.

Small Molecule CMO/CDMO Market Outlook 2024-2033: Rising - Vimarsana News

Small Molecule CMO/CDMO Market Outlook 2024-2033: Rising

Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The

Xaira launches with $1B+ for AI drug development - Vimarsana News

Xaira launches with $1B+ for AI drug development

In one of the biggest startups ever, Xaira Therapeutics has launched with more than $1 billion from investors. The financing, according to BioWorld records, is roughly equivalent to Roivant Sciences Inc.’s $1.1 billion raise in August 2017 and Galderma Inc.’s $1 billion private placement in June 2023.